NASDAQ · MRVL
Marvell Technology, Inc.
$218.34-$33.31 (-13.24%)
Marvell Technology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.81% below the high.
Loading market information…
CNQ · CHAL.CN · CAD
Stock price, earnings
Quote as of May 6, 2022, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Chalice Brands Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Chalice Brands Ltd. is engaged in a comprehensive range of cannabis operations, including cultivation, processing, wholesale distribution, and retail sales. The company manages a network of sixteen retail dispensaries across Oregon, featuring six flagship Chalice Farms locations, five operating as Homegrown Oregon, four under the Cannabliss and Co. banner, and one Left Coast Connections store. Additionally, Chalice Brands manufactures and distributes various cannabis products, such as Private Stash distillate vaporizer cartridges, single-serve fruit chew blasts offered under the Golden and Chalice brands, RXO ethanol extract products, and Elysium Fields live resin and distillate vaporizer cartridges. The company's product portfolio also encompasses cannabis oil products sold under the Chalice, Golden, Private Stash, Elysium Fields, and Jackpot brand names. Headquartered in Toronto, Canada, the firm was previously known as Golden Leaf Holdings Ltd. before adopting its current name, Chalice Brands Ltd., in May 2021.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$218.34-$33.31 (-13.24%)
Marvell Technology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.81% below the high.
CA$5.10-CA$3.40 (-40.0%)
IM Cannabis Corp.’s quoted price sits in the lower half of its reported 52-week range, 47.42% below the high.
CA$0.30+CA$0.04 (+13.46%)
Antibe Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.02% below the high.
CA$0.20CA$0.00 (0.0%)
EXMceuticals Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.11CA$0.00 (0.0%)
LexaGene Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
CA$0.10-CA$0.01 (-4.76%)
RIV Capital Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.40CA$0.00 (0.0%)
Orion Nutraceuticals Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.02-$0.00 (-20.0%)
Numinus Wellness Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.91% below the high.
